SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Endocrinol Metab (Seoul). 2020;35(1):157-164.

Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service.

, , , ,

제1저자 김정희, 문혜미 · 교신저자 김신곤

소속 (4)
  1. Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  2. Department of Biostatistics, Korea University College of Medicine, Seoul, Korea.
  3. Division of Endocrinology and Metabolism, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.
  4. Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. k50367@korea.ac.kr.

Abstract

BACKGROUND Pheochromocytomas and paragangliomas (PPGLs) are rare endocrine tumors originating from chromaffin cells. PPGLs are associated with a high mortality rate and several complications. To date, no epidemiological studies have been conducted on PPGLs in Asia. This study aimed to investigate the epidemiology and prognosis of PPGLs in Korea using nationwide data.

METHODS Using the National Health Insurance Service Database, subjects with a principal diagnosis of PPGLs on two or more occasions between 2003 and 2014 who satisfied the operational definition of PPGLs were included. Incidence, prevalence, complications, metastasis, and mortality were investigated.

RESULTS In total, 1048 subjects with a mean age of 47.6±16.1 years were included. There was no sex preponderance. The overall prevalence of PPGLs was 2.13 per 100,000 persons, and the overall age-standardized incidence rate was 0.18 per 100,000 person-years. Malignant PPGLs accounted for 17.7% (185 of 1,048) of cases, and 94 subjects exhibited metastasis at the time of diagnosis. Among initially non-metastatic PPGLs, 9.5% (nine of 954) eventually metastasized after a mean duration of 78.1±41.4 months. The 5-year survival rates for non-metastatic and metastatic PPGLs at diagnosis were 97% and 84%, respectively. Multivariable Cox regression models adjusted for covariates showed that metastatic PPGLs were associated with a 2.40-fold higher risk of mortality than non-metastatic PPGLs (95% confidence interval, 1.38 to 4.17; P=0.002).

CONCLUSION PPGLs are rare in Korea, and the prognosis of these endocrine tumors varies depending on whether they are benign or malignant. This epidemiological study paves the way for further research on PPGLs.

Copyright © 2020 Korean Endocrine Society.

Keywords

EpidemiologyIncidenceMortalityParagangliomaPheochromocytomaPrevalencePrognosis

Figures

Fig. 1
Fig. 1 Flow chart of study subjects. PPGLs, pheochromocytomas and paragangliomas.
Fig. 2
Fig. 2 (A) Age and (B) sex distributions of study subjects with pheochromocytomas and paragangliomas. The sex of three subjects was not identified.
Fig. 3
Fig. 3 The number of study subjects and the incidence rate of pheochromocytomas and paragangliomas by year.
Fig. 4
Fig. 4 Kaplan-Meier survival curve for metastasis in non-metastatic pheochromocytomas and paragangliomas at diagnosis.
Fig. 5
Fig. 5 Kaplan-Meier survival curve according to metastasis at diagnosis. PPGL, pheochromocytomas and paraganglioma.

그림 출처: PubMed Central 공개 논문 (PMC7090309)

Comment · 정정

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

그 밖의 정보
출판 형태
Journal Article, Research Support, Non-U.S. Gov't
저널
Endocrinology and metabolism (Seoul, Korea) · eISSN 2093-5978
MeSH
Adolescent · Adrenal Gland Neoplasms / epidemiology / pathology / surgery · Adult · Aged · Aged, 80 and over · Child · Child, Preschool · Databases, Factual / statistics & numerical data · Female · Follow-Up Studies · Humans · Infant · Infant, Newborn · Male · Middle Aged · National Health Programs / statistics & numerical data · Paraganglioma / epidemiology / pathology / surgery · Pheochromocytoma / epidemiology / pathology / surgery · Prognosis · Republic of Korea / epidemiology · Survival Rate · Young Adult
연구비
Korea Health Industry Development Institute HI17C1926
참고문헌
29편